Susmed Inc
TSE:4263
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Susmed Inc
TSE:4263
|
JP |
|
Premier Ltd
NSE:PREMIER
|
IN |
|
P
|
Pan Entertainment Co Ltd
KOSDAQ:068050
|
KR |
|
Goodluck India Ltd
NSE:GOODLUCK
|
IN |
|
Il Sole 24 Ore SpA
F:4IL1
|
IT |
|
M
|
Metro Bank Holdings PLC
OTC:MTRBF
|
UK |
|
G
|
Geely Automobile Holdings Ltd
XHAM:GRU
|
HK |
|
S
|
Smartgroup Corporation Ltd
ASX:SIQ
|
AU |
|
S
|
SR Bancorp Inc
NASDAQ:SRBK
|
US |
|
DFI Inc
TWSE:2397
|
TW |
|
Fredun Pharmaceuticals Ltd
BSE:539730
|
IN |
|
Code Green Apparel Corp
OTC:CGAC
|
US |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
US |
|
Cascades Inc
TSX:CAS
|
CA |
|
Yealink Network Technology Co Ltd
SZSE:300628
|
CN |
|
Asia-Pacific Strategic Investments Ltd
SGX:5RA
|
SG |
Susmed Inc
SUSMED, Inc. engages in the development of medical equipment and software systems. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2021-12-24. The firm operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.
SUSMED, Inc. engages in the development of medical equipment and software systems. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2021-12-24. The firm operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.
